2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Mizugaki M et al. | Microdetermination of 2,3-dinor-6-ketoprostaglandin F1 alpha in human urine using gas chromatography-high-resolution selected-ion monitoring. | 1994 | J. Chromatogr. B, Biomed. Appl. | pmid:7952110 |
Daniel VC et al. | Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry. | 1994 | J. Chromatogr. B, Biomed. Appl. | pmid:8205238 |
Ylikorkala O et al. | Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins. | 1987 | J. Clin. Endocrinol. Metab. | pmid:2960690 |
Ylikorkala O et al. | Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants. | 1986 | J. Clin. Endocrinol. Metab. | pmid:3536979 |
Fitzgerald DJ et al. | Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis. | 1988 | J. Clin. Invest. | pmid:3183064 |
Dowd NP et al. | Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo. | 2001 | J. Clin. Invest. | pmid:11518732 |
Song WL et al. | Niacin and biosynthesis of PGDâ‚‚by platelet COX-1 in mice and humans. | 2012 | J. Clin. Invest. | pmid:22406532 |
Neiman J et al. | Urinary excretion of 2, 3-dinor-6-keto prostaglandin F1 alpha and platelet thromboxane formation during ethanol withdrawal in alcoholics. | 1987 | J. Clin. Pathol. | pmid:3584500 |
Kimblad PO et al. | Prostanoid release after lung transplantation. | 1996 | J. Heart Lung Transplant. | pmid:8913917 |
Barden AE et al. | Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? | 1999 | J. Hypertens. | pmid:10489109 |
Rasmanis G et al. | Prostacyclin production in myocardial infarction in the acute phase and during follow-up. | 1991 | J. Intern. Med. | pmid:1997639 |
Morrow JD et al. | Increased formation of thromboxane in vivo in humans with mastocytosis. | 1999 | J. Invest. Dermatol. | pmid:10417625 |
Mastrogiannis DS et al. | Cocaine decreases urinary prostacyclin release in pregnancy: correlation with uterine and umbilical Doppler velocimetry. | 2003 | J. Matern. Fetal. Neonatal. Med. | pmid:15061316 |
Kuehl PG et al. | Systemic production of prostacyclin and thromboxane A2 does not correlate with patency of the ductus arteriosus in very low birth weight infants. | 1986 | J. Pediatr. | pmid:3519915 |
Brown NJ et al. | Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin. | 1996 | J. Pharmacol. Exp. Ther. | pmid:8930174 |
Catella-Lawson F et al. | Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. | 1999 | J. Pharmacol. Exp. Ther. | pmid:10215647 |
Capone ML et al. | Human pharmacology of naproxen sodium. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17473175 |
Neiman J et al. | Effects of a small dose of ethanol and calcium carbimide-induced acetaldehyde intoxication on human platelet aggregation, associated thromboxane formation and urinary excretion of 2,3-dinor-6-keto prostaglandin F1 alpha. | 1987 | J. Toxicol. Clin. Toxicol. | pmid:3612897 |
Lin JS et al. | The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence. | 1992 | J. Urol. | pmid:1635125 |
Hashimoto K et al. | Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness. | 2004 | J. Virol. | pmid:15367596 |